Analyst Ratings for Global Blood Therapeutics (GBT)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.4 / 10
Percentile Rank: 44%
Rating Score: 4.4 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/9/2022 | Wells Fargo | Jim Birchenough | Downgrade | Equal Weight (Overweight) |
68.50 (66.00) |
66.60 (68.49) |
2.84% | Details |
| 8/9/2022 | RBC Capital | Gregory Renza | Downgrade | Sector Perform (Outperform) |
68.50 (60.00) |
63.84 (68.49) |
7.28% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


